Rehan Verjee is the founder of Precede Biosciences. Precede Biosciences has raised $84M in total funding. Latest round: Series B. Based in Boston, US.
Rehan Verjee is the Co-founder and CEO of Precede Biosciences, a Boston-based precision diagnostics company. He co-founded the company through the 4:59 Initiative at 5AM Ventures, emerging from stealth mode in October 2023. Verjee leads the scaling of next-generation technology that profiles epigenomic regulators using molecular techniques and machine learning.
Full founder directory · Investor directory · Company funding database · Fundraising library